Por favor, use este identificador para citar o enlazar este ítem:
https://doi.org/10.1111/tan.15160


Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Castro-Santos, Patricia | - |
dc.contributor.author | Rojas-Martinez, Augusto | - |
dc.contributor.author | Riancho, José A. | - |
dc.contributor.author | Lapunzina, Pablo | - |
dc.contributor.author | Flores, Carlos | - |
dc.contributor.author | Carracedo, Angel | - |
dc.contributor.author | Díaz-Peña, Roberto | - |
dc.contributor.author | García-Vázquez, Elisa | - |
dc.contributor.author | Scourge Cohort Group | - |
dc.contributor.other | Facultades, Departamentos, Servicios y Escuelas::Departamentos de la UMU::Medicina Interna | es |
dc.date.accessioned | 2024-07-08T10:51:19Z | - |
dc.date.available | 2024-07-08T10:51:19Z | - |
dc.date.issued | 2023-08-01 | - |
dc.identifier.citation | HLA: Immune Response Genetics. 2023; 102(6): 731-739 | es |
dc.identifier.issn | Print: 2059-2302 | - |
dc.identifier.issn | Electronic: 2059-2310 | - |
dc.identifier.uri | http://hdl.handle.net/10201/142903 | - |
dc.description | © 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. This document is the Published, version of a Published Work that appeared in final form in HLA: Immune Response Genetics. To access the final edited and published work see https://doi.org/10.1111/tan.15160 | es |
dc.description.abstract | We analyzed the association between HLA polymorphisms and susceptibility to SARS-CoV-2 infection and disease severity. Genotyping data from a total of 9373 COVID-19-positive cases from the Spanish Coalition to Unlock Research on Host Genetics on COVID-19 (SCOURGE) consortium and 5943 population controls were included in the study. We found an association of the alleles HLA-B*14:02 and HLA-C*08:02 with a lower risk to COVID-19 infection (p = 0.006, OR = 0.84, 95% CI = [0.75–0.95], p = 0.024, OR = 0.86, 95% CI = [0.78–0.95], respectively). We also found the alleles HLA-A*11:01 and HLA- C*04:01 associated with disease severity (p = 0.033, OR = 1.16, 95% CI = [1.04–1.31], p = 0.045, OR = 1.14, 95% CI = [1.05–1.25], respectively). These results suggest that an effective presentation of viral peptides by HLA class I alleles involve a faster infection clearance, decreasing the susceptibility and severity of COVID-19. | es |
dc.format | application/pdf | es |
dc.format.extent | 9 | es |
dc.language | eng | es |
dc.publisher | John Wiley & Sons | es |
dc.relation | Instituto de Salud Carlos III, Grant/Award. Numbers: COV20_00622, CP21/00003; European Union (ERDF) | es |
dc.rights | info:eu-repo/semantics/embargoedAccess | es |
dc.subject | COVID-19 | es |
dc.subject | HLA evolutionary divergence | es |
dc.subject | HLA-A*11:01 | es |
dc.subject | HLA-C*04:01 | es |
dc.subject | Immunogenetics | es |
dc.subject | SARS-CoV-2 | es |
dc.title | HLA-A*11:01 and HLA-C*04:01 are associated with severe COVID-19 | es |
dc.type | info:eu-repo/semantics/article | es |
dc.relation.publisherversion | https://onlinelibrary.wiley.com/doi/10.1111/tan.15160 | es |
dc.embargo.terms | Si | - |
dc.identifier.doi | https://doi.org/10.1111/tan.15160 | - |
Aparece en las colecciones: | Artículos: Medicina |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
HLA are associated with severe COVID‐19.pdf | 1,19 MB | Adobe PDF | ![]() Visualizar/Abrir Solicitar una copia |
Los ítems de Digitum están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.